FDA Expects To Review Half Of All Generic Drugs By Six-Month Goal In 2001
FDA projects it will be able to review 50% of generic drug applications within six months in FY 2001.
You may also be interested in...
The Center for Biologics Evaluation & Research is implementing a new application database that is expected to improve its ability to keep track of post-marketing commitments and changes to applications.
FDA's Office of Generic Drugs estimates it could approve or tentatively approve 315 generic drug applications in calendar year 2000, a 30% increase from 1999.
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011